ESMO World Congress on Gastrointestinal Cancer 2020

At the 2020 ESMO WCGC virtual meeting, Boehringer Ingelheim presented the latest data on their gastrointestinal cancer research program.


See below for more information and downloadable versions of these publications.


Wednesday, July 1 – Saturday, July 4, 2020
Virtual format

Explore our latest clinical data during the scientific program at ESMO WCGC.

Filter by:
Presentation Type
  • All presentation types
  • Oral Presentation
  • Poster Presentation
  • e-Presentation
Tumor Type
  • All tumor types
Wednesday 1 July - Saturday 4 July 2020
A first-in-human phase Ia/b, open-label, multicentre, dose-escalation study of BI 905711 in patients with advanced gastrointestinal cancers.
Author(s): Harding et al.

Poster number: P-169

Poster Presentation
Tumor Type(s): Gastrointestinal cancer
Presentation Number: 473
There are no publications which meet your criteria on this date

Find out more about other oncology events

Click here to find out more about other oncology meetings, congresses, symposia and activities sponsored by Boehringer Ingelheim.


Pipeline compounds shown here are under pre-clinical and/or clinical investigation, and have not been approved. Their safety and efficacy have not been established.


© 2020 Boehringer Ingelheim International GmbH. All rights reserved.


Page last updated: July 2020